Author:
Alexdottir Marta S.,Pehrsson Martin,Domislovic Viktor,Godskesen Line E.,Krag Aleksander,Kjeldsen Jens,Brinar Marko,Barisic Ana,Bay-Jensen Anne-Christine,Karsdal Morten A.,Krznaric Zeljko,Mortensen Joachim H.
Abstract
AbstractNeutrophils play a significant role in sustaining chronic inflammation in Inflammatory Bowel Disease. The intestinal basement membrane acts as a barrier for immunological homeostasis, where the α3 and α4 chains of type IV collagen are expressed on the mucosal surface. We wanted to develop a biomarker reflecting early tissue injury, providing an opportunity for intervention. Two competitive enzyme-linked immunosorbent assays (ELISAs) quantifying human neutrophil elastase (HNE) degraded neo-epitopes of COL4A3 and COL4A4 were developed and investigated in two observational cohorts (n = 161, n = 100). A biomarker of MMP-mediated degradation of COL4A1 (C4M) was used for comparison. In Cohort 1, patients with mild endoscopic ulcerative colitis showed elevated levels of C4A3-HNE compared to those with severe disease. C4M had a strong positive correlation with disease activity. C4A3-HNE/C4M provided superior discrimination between mild and severe endoscopic disease and negatively correlated to disease activity. In Cohort 2, C4A4-HNE and C4A4-HNE/C4M showed similar trends. C4A3-HNE and C4A4-HNE possibly reflect early intestinal tissue injury. Combining the markers with a biomarker of another α-chain of the same collagen provides information on two distinct stages of mucosal damage. These biomarkers may be used to monitor disease flare-up in patients in remission, reducing the need for frequent endoscopic procedures.
Funder
Den Danske Forskningsfond
Publisher
Springer Science and Business Media LLC
Reference30 articles.
1. McDowell, C., Farooq, U. & Haseeb, M. Inflammatory Bowel Disease. 2022. http://www.ncbi.nlm.nih.gov/pubmed/30137275.
2. McGuckin, M. A., Eri, R., Simms, L. A., Florin, T. H. J. & Radford-Smith, G. Intestinal barrier dysfunction in inflammatory bowel diseases. Inflamm. Bowel Dis. 15, 100–113. https://doi.org/10.1002/ibd.20539 (2009).
3. Antoni, L., Nuding, S., Wehkamp, J. & Stange, E. F. Intestinal barrier in inflammatory bowel disease. World J. Gastroenterol. 20, 1165–1179. https://doi.org/10.3748/wjg.v20.i5.1165 (2014).
4. Vogelsang, H. Do changes in intestinal permeability predict disease relapse in Crohn’s disease?. Inflamm. Bowel Dis. 14(Suppl 2), 162–163. https://doi.org/10.1097/00054725-200810001-00077 (2008).
5. D’Inca, R. et al. Can permeability to sugars predict relapses in Crohn’s disease?. Gut 34, S50–S73 (1993).